Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-16-149032
Filing Date
2016-10-06
Accepted
2016-10-06 09:45:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 8-K a16-19567_18k.htm 425 28336
2 EX-10.1 a16-19567_1ex10d1.htm EX-10.1 35428
3 EX-99.1 a16-19567_1ex99d1.htm EX-99.1 31152
4 GRAPHIC g195671mmi001.jpg GRAPHIC 5213
  Complete submission text file 0001104659-16-149032.txt   103797
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Animal Health, Inc. (Filed by) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Animal Health, Inc. (Subject) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36714 | Film No.: 161924016
SIC: 2834 Pharmaceutical Preparations